Tumor-intrinsic oncogenic signaling like the inactivation of PIK3 pathway through phosphate and and tensin homolog (PTEN) activation has been shown to be associated with better survival in melanoma patients undergoing immunotherapy [63]. The gene discussed is PIK3CG; the disease is neoplasm.